Transcriptomics Market expected to reach $33.68 Billion by 2031

The transcriptomics market is an emerging market with huge growth potential. Recent technological advancements are facilitating the adoption of the technology at a rapid pace. Transcriptomics offers the ability to isolate a single cell with specific phenotypes from a heterogeneous mixture, along with gene expression analysis and protein expression analysis. The unique feature of transcriptomics technology to integrate the data from various molecules and from different cells to study cell-to-cell differentiation enables the study of mechanisms that are visible at a transcriptomic level.

The growth in this market is expected to be driven by the decrease in the cost of sequencing, the global increase in the application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches. The growth of other technologies, such as in-situ hybridization, can be attributed to the increased clinical research to understand the involvement of molecular pathology in the diagnosis and prognosis of genetic disorders. Based on region, North America holds the largest share in the market, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period 2021-2031.

The healthcare experts have found the transcriptomics market to be one of the stable markets, and the global market is predicted to grow at a CAGR of 20.11% during the forecast period 2021-2031.

Key Questions Answered in this Report:

•   How is next-generation sequencing technology affecting the transcriptomics market?
•   What are the major market drivers, challenges, and opportunities in the global transcriptomics market?
•   What are the underlying structures resulting in the emerging trends within the global transcriptomics market?
•   How is the COVID-19 pandemic impacting the global transcriptomics market landscape?
•   What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
•   What are the key regulatory implications in developed and developing regions pertaining to transcriptomics?
•   What are the potential entry barriers expected to be faced by the companies willing to enter a particular region for the development of transcriptomics?
•   How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
o   Product (instruments, consumables, and software)
o   Technology (next-generation sequencing, polymerase chain reaction, microarray, in-situ hybridization, and other technologies)
o   Application (drug discovery and development, diagnostics, cell biology, single cell analysis, gene expression, and other applications)
o   End User (academic and research institutions, biotechnology and biopharmaceutical companies, and other end users)
o   Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
•   What are the growth opportunities for the companies in the region of their operation?
•   What are the major applications for the companies in the region of their operation?
•   Who are the leading players with significant offerings in the global transcriptomics market?
•   Which companies are anticipated to be highly disruptive in the future, and why?
•   What are the current unmet needs that are being faced in the global transcriptomics market?

Request a Sample - https://bisresearch.com/requestsample?id=1197&type=download

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: • Industry Analysis ...

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Hyperspectral Imaging Market Projections , Upcoming Trends Focus on Long-Term Impact of Covid-19 and Forecast By 2027

The global hyperspectral imaging market was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining. The hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense sectors, increased food safety concerns, and increasing awareness regarding early diagnosis of diseases. COVID-19 Impact and Post-COVID-19 Scenario The COVID-19 pandemic had a debilitating impact on the global ecosystem. The pandemic led to a shutdown of production facilities, which do not come under essential goods, which led to a negative impact on se...

Market Research Reports

Search This Blog